BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18724429)

  • 1. [Criteria for intoxication in the evaluation of severity of endotoxicosis, the efficiency of ozone therapy and traditional treatment in patients with diabetes mellitus complicated by pyonecrotic lesions of the lower extremities].
    Gazin IK
    Klin Lab Diagn; 2008 Jun; (6):21-3. PubMed ID: 18724429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiological aspects of endotoxicosis complicated with purulent infection of the foot and correction of endotoxicosis with conventional treatment and with application of ozonized physiological solution in patients suffering from diabetes mellitus].
    Gazin IK
    Patol Fiziol Eksp Ter; 2008; (4):23-5. PubMed ID: 19198268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The informative value of markers in the evaluation of the severity of endotoxicosis in pyonecrotic lesions of the lower limbs in diabetic patients].
    Gazin IK
    Klin Lab Diagn; 2008 Dec; (12):17-20. PubMed ID: 19198274
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of different methods of ozone therapy in vascular complications of diabetes mellitus].
    Kulikov AG; Turova EA; Shcherbina TM; Kisileva OM
    Vopr Kurortol Fizioter Lech Fiz Kult; 2002; (5):17-20. PubMed ID: 12532590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of purulent and necrotic lesions of the lower extremities in patients with diabetes mellitus].
    Ohonovsky? VK; Podil?hak MD; Matskiv AS; Kravets SL; Tsemekhin BD
    Klin Khir (1962); 1993; (9-10):37-40. PubMed ID: 8158919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of pyonecrotic complications in diabetic macroangiopathy].
    Dibirov MD; Gadzhimuradov RU; Evseev IuN; Novosel'tsev OS
    Khirurgiia (Mosk); 2001; (3):29-33. PubMed ID: 11400448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical course of purulent and necrotic complications in diabetes mellitus].
    Genyk SN; Grushetskiĭ NN
    Khirurgiia (Mosk); 1993 May; (5):28-31. PubMed ID: 8089982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ozone therapy effectiveness in patients with ulcerous lesions due to diabetes mellitus.
    Rosul MV; Patskan BM
    Wiad Lek; 2016; 69(1):7-9. PubMed ID: 27162287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of ozone in patients with diabetic foot.
    Martínez-Sánchez G; Al-Dalain SM; Menéndez S; Re L; Giuliani A; Candelario-Jalil E; Alvarez H; Fernández-Montequín JI; León OS
    Eur J Pharmacol; 2005 Oct; 523(1-3):151-61. PubMed ID: 16198334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Central hemodynamics during conduction anesthesia in patients with pyonecrotic forms of the diabetic foot].
    Orudzheva SA; Zviagin AA; Kurochkina AI
    Anesteziol Reanimatol; 2005; (3):15-7. PubMed ID: 16076038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major ozonated autohemotherapy in chronic limb ischemia with ulcerations.
    de Monte A; van der Zee H; Bocci V
    J Altern Complement Med; 2005 Apr; 11(2):363-7. PubMed ID: 15865505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Regional anesthesia and timely treatment for neuropathy in patients with pyonecrotic forms of the diabetic foot].
    Orudzheva SA; Zviagin AA; Simonenkov AP; Tsvetkov VO; Kurochkina AI; Klenskiĭ SK; Braverman IB
    Anesteziol Reanimatol; 2005; (2):35-7. PubMed ID: 15938094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE STUDY OF ACTION THE OZONE IN THE SURGICAL TREATMENT OF INFLAMMATORY PROCESSES BY DIABETES MELLITUS.
    Karatieieva SY; Muzyka NY; Yakovets KI; Bakun OV; Slobodian KV
    Wiad Lek; 2021; 74(4):884-886. PubMed ID: 34155997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TREATMENT OF PYOINFLAMMATORY COMPLICATIONS WITH INDIVIDUALLY SELECTED OZONE DOSE IN PATIENTS WITH DIABETES.
    Karatieieva S; Makarova O; Yurkiv O; Semenenko S; Berezova M
    Georgian Med News; 2018 Feb; (Issue):91-94. PubMed ID: 29578432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ULTRASTRUCTURAL CHANGES OF WOUND MACROPHAGES UNDER THE INFLUENCE OF INTRAVENOUS OZONE THERAPY IN PATIENTS WITH DIABETES AND INFLAMMATORY PROCESSES OF SOFT TISSUES.
    Karatieieva S; Muzyka N; Semenenko S; Bakun O; Kozlovskaya I
    Georgian Med News; 2018 Mar; (276):98-101. PubMed ID: 29697390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new method for detoxifying the lymph in patients with cholestatic endotoxicosis].
    Fedoseev AV; Gushcha AL; Tarasenko SV; Zaĭtsev OV
    Vestn Khir Im I I Grek; 1999; 158(6):76-8. PubMed ID: 10709277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical components in patients with diabetes type II and ischemia of the lower extremities].
    Turczyński B; Sroczyński J; Antoszewski Z; Matyszczyk B; Krupa G; Młynarski J; Strugala M
    Pol Tyg Lek; 1991 Sep 9-30; 46(37-39):708-10. PubMed ID: 1669138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correction of the glicemia level in elderly and senile patients with diabetes mellitus, operated for purulent-necrotic foot lesion].
    Ivashchenko VV; Kolkin Iag; Koval'chuk VS; Ivashchenko AV
    Klin Khir; 2005 Aug; (8):51-4. PubMed ID: 16445063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers.
    Wainstein J; Feldbrin Z; Boaz M; Harman-Boehm I
    Diabetes Technol Ther; 2011 Dec; 13(12):1255-60. PubMed ID: 21751891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complex treatment of patients with purulent-necrotic complications of diabetes mellitus].
    Dmytriiev BI; Demydov VM; Kotik IuM
    Klin Khir; 2001 Aug; (8):13-4. PubMed ID: 11794096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.